White AC Jr. Cryptosporidiosis (Cryptosporidium species). Bennett JE, Dolin R, Blaser MK, eds. Principles and Practice of Infectious Diseases. Philadelphia, Pa: Elsevier Inc; 2020. 3410-3420.
Checkley W, White AC Jr, Jaganath D, Arrowood MJ, Chalmers RM, Chen XM, et al. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect Dis. 2015 Jan. 15 (1):85-94. [QxMD MEDLINE Link].
Bouzid M, Hunter PR, Chalmers RM, Tyler KM. Cryptosporidium pathogenicity and virulence. Clin Microbiol Rev. 2013 Jan. 26(1):115-34. [QxMD MEDLINE Link]. [Full Text].
Khalil IA, Troeger C, Rao PC, et al. Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study. Lancet Glob Health. 2018 Jul. 6 (7):e758-e768. [QxMD MEDLINE Link].
Korpe PS, Valencia C, Haque R, et al. Epidemiology and Risk Factors for Cryptosporidiosis in Children From 8 Low-income Sites: Results From the MAL-ED Study. Clin Infect Dis. 2018 Nov 13. 67 (11):1660-1669. [QxMD MEDLINE Link].
Tomczak E, McDougal AN, White Jr AC. Resolution of Cryptosporidiosis in Transplant Recipients: Review of the Literature and Presentation of a Renal Transplant Patient Treated With Nitazoxanide, Azithromycin, and Rifaximin. Open Forum Infect Dis. 2022. 9:[QxMD MEDLINE Link].
Šlapeta J. DNA barcoding of Cryptosporidium. Parasitology. 2018 Apr. 145 (5):574-584. [QxMD MEDLINE Link].
Nader JL, Mathers TC, Ward BJ, Pachebat JA, Swain MT, Robinson G, et al. Evolutionary genomics of anthroponosis in Cryptosporidium. Nat Microbiol. 2019 May. 4 (5):826-836. [QxMD MEDLINE Link].
Gharpure R, Perez A, Miller AD, Wikswo ME, Silver R, Hlavsa MC. Cryptosporidiosis Outbreaks - United States, 2009-2017. MMWR Morb Mortal Wkly Rep. 2019 Jun 28. 68 (25):568-572. [QxMD MEDLINE Link].
Chalmers RM, Robinson G, Elwin K, Elson R. Analysis of the Cryptosporidium spp. and gp60 subtypes linked to human outbreaks of cryptosporidiosis in England and Wales, 2009 to 2017. Parasit Vectors. 2019 Mar 12. 12 (1):95. [QxMD MEDLINE Link].
Chalmers RM, Smith R, Elwin K, Clifton-Hadley FA, Giles M. Epidemiology of anthroponotic and zoonotic human cryptosporidiosis in England and Wales, 2004-2006. Epidemiol Infect. 2011 May. 139(5):700-12. [QxMD MEDLINE Link].
Okhuysen PC, Chappell CL, Crabb JH, Sterling CR, DuPont HL. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J Infect Dis. 1999 Oct. 180 (4):1275-81. [QxMD MEDLINE Link].
Chappell CL, Okhuysen PC, Langer-Curry R, Widmer G, Akiyoshi DE, Tanriverdi S, et al. Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg. 2006 Nov. 75 (5):851-7. [QxMD MEDLINE Link].
Garza A, Lackner A, Aye P, D'Souza M, Martin P Jr, Borda J, et al. Substance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques. J Med Primatol. 2008 Jun. 37 (3):109-15. [QxMD MEDLINE Link].
Goodgame RW, Kimball K, Ou CN, White AC Jr, Genta RM, Lifschitz CH, et al. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology. 1995 Apr. 108 (4):1075-82. [QxMD MEDLINE Link].
Kelly P, Makumbi FA, Carnaby S, Simjee AE, Farthing MJ. Variable distribution of Cryptosporidium parvum in the intestine of AIDS patients revealed by polymerase chain reaction. Eur J Gastroenterol Hepatol. 1998 Oct. 10 (10):855-8. [QxMD MEDLINE Link].
Yoder JS, Beach MJ. Cryptosporidium surveillance and risk factors in the United States. Exp Parasitol. 2010 Jan. 124(1):31-9. [QxMD MEDLINE Link].
Painter JE, Hlavsa MC, Collier SA, Xiao L, Yoder JS, Centers for Disease Control and Prevention. Cryptosporidiosis surveillance -- United States, 2011-2012. MMWR Suppl. 2015 May 1. 64 (3):1-14. [QxMD MEDLINE Link].
Bouzid M, Kintz E, Hunter PR. Risk factors for Cryptosporidium infection in low and middle income countries: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2018 Jun. 12 (6):e0006553. [QxMD MEDLINE Link].
Painter JE, Gargano JW, Yoder JS, Collier SA, Hlavsa MC. Evolving epidemiology of reported cryptosporidiosis cases in the United States, 1995-2012. Epidemiol Infect. 2016 Jun. 144 (8):1792-802. [QxMD MEDLINE Link].
Centers for Disease Control and Prevention. Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables. CDC. Available at https://wonder.cdc.gov/nndss/nndss_annual_tables_menu.asp. Accessed: November 6, 2019.
Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, et al. Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis. 2011 Jan. 17(1):7-15. [QxMD MEDLINE Link]. [Full Text].
Mac Kenzie WR, Hoxie NJ, Proctor ME, Gradus MS, Blair KA, Peterson DE, et al. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med. 1994 Jul 21. 331(3):161-7. [QxMD MEDLINE Link].
Hlavsa MC, Cikesh BL, Roberts VA, Kahler AM, Vigar M, Hilborn ED, et al. Outbreaks Associated with Treated Recreational Water - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2018 May 18. 67 (19):547-551. [QxMD MEDLINE Link].
Vandenberg O, Robberecht F, Dauby N, Moens C, Talabani H, Dupont E, et al. Management of a Cryptosporidium hominis outbreak in a day-care center. Pediatr Infect Dis J. 2012 Jan. 31 (1):10-5. [QxMD MEDLINE Link].
Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, et al. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS. 2010 Jun 19. 24 (10):1549-59. [QxMD MEDLINE Link].
sem*nza JC, Nichols G. Cryptosporidiosis surveillance and water-borne outbreaks in Europe. Euro Surveill. 2007 May 1. 12(5):E13-4. [QxMD MEDLINE Link].
Sow SO, Muhsen K, Nasrin D, et al. The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS). PLoS Negl Trop Dis. 2016 May. 10 (5):e0004729. [QxMD MEDLINE Link].
Platts-Mills JA, Liu J, Rogawski ET, et al. Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study. Lancet Glob Health. 2018 Dec. 6 (12):e1309-e1318. [QxMD MEDLINE Link].
Wang RJ, Li JQ, Chen YC, Zhang LX, Xiao LH. Widespread occurrence of Cryptosporidium infections in patients with HIV/AIDS: Epidemiology, clinical feature, diagnosis, and therapy. Acta Trop. 2018 Nov. 187:257-263. [QxMD MEDLINE Link].
Ajjampur SS, Rajendran P, Ramani S, Banerjee I, Monica B, Sankaran P, et al. Closing the diarrhoea diagnostic gap in Indian children by the application of molecular techniques. J Med Microbiol. 2008 Nov. 57:1364-8. [QxMD MEDLINE Link].
Nair P, Mohamed JA, DuPont HL, Figueroa JF, Carlin LG, Jiang ZD, et al. Epidemiology of cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg. 2008 Aug. 79(2):210-4. [QxMD MEDLINE Link]. [Full Text].
Wanyiri JW, Kanyi H, Maina S, Wang DE, Steen A, Ngugi P, et al. Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses. Am J Trop Med Hyg. 2014 Aug. 91 (2):319-28. [QxMD MEDLINE Link].
Wang ZD, Liu Q, Liu HH, Li S, Zhang L, Zhao YK, et al. Prevalence of Cryptosporidium, microsporidia and Isospora infection in HIV-infected people: a global systematic review and meta-analysis. Parasit Vectors. 2018 Jan 9. 11 (1):28. [QxMD MEDLINE Link].
Guerrant DI, Moore SR, Lima AA, Patrick PD, Schorling JB, Guerrant RL. Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg. 1999 Nov. 61(5):707-13. [QxMD MEDLINE Link].
Sponseller JK, Griffiths JK, Tzipori S. The evolution of respiratory Cryptosporidiosis: evidence for transmission by inhalation. Clin Microbiol Rev. 2014 Jul. 27 (3):575-86. [QxMD MEDLINE Link].
Naseer M, Dailey FE, Juboori AA, Samiullah S, Tahan V. Epidemiology, determinants, and management of AIDS cholangiopathy: A review. World J Gastroenterol. 2018 Feb 21. 24 (7):767-774. [QxMD MEDLINE Link].
Lanternier F, Amazzough K, Favennec L, Mamzer-Bruneel MF, Abdoul H, Tourret J, et al. Cryptosporidium spp. Infection in Solid Organ Transplantation: The Nationwide "TRANSCRYPTO" Study. Transplantation. 2017 Apr. 101 (4):826-830. [QxMD MEDLINE Link].
Hashmey R, Smith NH, Cron S, Graviss EA, Chappell CL, White AC Jr. Cryptosporidiosis in Houston, Texas. A report of 95 cases. Medicine (Baltimore). 1997 Mar. 76 (2):118-39. [QxMD MEDLINE Link].
Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 2002 Nov 2. 360(9343):1375-80. [QxMD MEDLINE Link].
Adler S, Widerström M, Lindh J, Lilja M. Symptoms and risk factors of Cryptosporidium hominis infection in children: data from a large waterborne outbreak in Sweden. Parasitol Res. 2017 Oct. 116 (10):2613-2618. [QxMD MEDLINE Link].
Korpe PS, Haque R, Gilchrist C, Valencia C, Niu F, Lu M, et al. Natural History of Cryptosporidiosis in a Longitudinal Study of Slum-Dwelling Bangladeshi Children: Association with Severe Malnutrition. PLoS Negl Trop Dis. 2016 May. 10 (5):e0004564. [QxMD MEDLINE Link].
O'connor RM, Shaffie R, Kang G, Ward HD. Cryptosporidiosis in patients with HIV/AIDS. AIDS. 2011 Mar 13. 25(5):549-60. [QxMD MEDLINE Link].
Garcia LS, Arrowood M, Kokoskin E, Paltridge GP, Pillai DR, Procop GW, et al. Laboratory Diagnosis of Parasites from the Gastrointestinal Tract. Clin Microbiol Rev. 2018 Jan. 31 (1):[QxMD MEDLINE Link].
Khurana S, Chaudhary P. Laboratory diagnosis of cryptosporidiosis. Trop Parasitol. 2018 Jan-Jun. 8 (1):2-7. [QxMD MEDLINE Link].
Robinson G, Chalmers RM. Cryptosporidium Diagnostic Assays: Microscopy. Methods Mol Biol. 2020. 2052:1-10. [QxMD MEDLINE Link].
Chalmers RM, Campbell BM, Crouch N, Charlett A, Davies AP. Comparison of diagnostic sensitivity and specificity of seven Cryptosporidium assays used in the UK. J Med Microbiol. 2011 Nov. 60:1598-604. [QxMD MEDLINE Link].
Freeman K, Mistry H, Tsertsvadze A, Royle P, McCarthy N, Taylor-Phillips S, et al. Multiplex tests to identify gastrointestinal bacteria, viruses and parasites in people with suspected infectious gastroenteritis: a systematic review and economic analysis. Health Technol Assess. 2017 Apr. 21 (23):1-188. [QxMD MEDLINE Link].
Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev. 2002 Jan. 15(1):145-54. [QxMD MEDLINE Link]. [Full Text].
Reynoso D, White Jr C. Nitazoxanide. Grayson M, ed. Kucers' The Use of Antibiotics: a clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. 7th ed. Boca Raton: Taylor and Francis Group; 2017. 3162-74.
Rossignol JF, Kabil SM, el-Gohary Y, Younis AM. Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clin Gastroenterol Hepatol. 2006 Mar. 4(3):320-4. [QxMD MEDLINE Link].
Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. 2001 Jul 1. 184 (1):103-6. [QxMD MEDLINE Link].
Smith NH, Cron S, Valdez LM, Chappell CL, White AC Jr. Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis. 1998 Sep. 178(3):900-3. [QxMD MEDLINE Link].
Rossignol JF. Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients. Aliment Pharmacol Ther. 2006 Sep 1. 24 (5):887-94. [QxMD MEDLINE Link].
Amadi B, Mwiya M, Sianongo S, Payne L, Watuka A, Katubulushi M, et al. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis. 2009 Dec 2. 9:195. [QxMD MEDLINE Link]. [Full Text].
Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. AIDSinfo. Available at https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed: November 6, 2019.
Centers for Disease Control and Prevention. DPDx - Laboratory Identification of Parasites of Public Health Concern: Cryptosporidiosis. CDC. Available at https://www.cdc.gov/dpdx/cryptosporidiosis/index.html. Accessed: November 6, 2019.
Bhadauria D, Goel A, Kaul A, Sharma RK, Gupta A, Ruhela V, et al. Cryptosporidium infection after renal transplantation in an endemic area. Transpl Infect Dis. 2015 Feb. 17 (1):48-55. [QxMD MEDLINE Link].
Chavez MA, White AC Jr. Novel treatment strategies and drugs in development for cryptosporidiosis. Expert Rev Anti Infect Ther. 2018 Aug. 16 (8):655-661. [QxMD MEDLINE Link].
Nachipo P, Hermann D, Quinnan G, Gordon MA, Van Voorhis WC, Iroh Tam PY. Evaluating the safety, tolerability, pharmaco*kinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial. Trials. 2018 Aug 23. 19 (1):456. [QxMD MEDLINE Link].
Love MS, Beasley FC, Jumani RS, Wright TM, Chatterjee AK, Huston CD, et al. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. PLoS Negl Trop Dis. 2017 Feb. 11 (2):e0005373. [QxMD MEDLINE Link].
Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. 2001 Jul 1. 184(1):103-6. [QxMD MEDLINE Link].
Stiff RE, Davies AP, Mason BW, Hutchings HA, Chalmers RM. Long-term health effects after resolution of acute Cryptosporidium parvum infection: a 1-year follow-up of outbreak-associated cases. J Med Microbiol. 2017 Nov. 66 (11):1607-1611. [QxMD MEDLINE Link].
FAQs
Cryptosporidiosis: Background, Etiology and Pathophysiology, Epidemiology? ›
Human cryptosporidiosis is caused by infection with
Epidemiology. Cryptosporidiosis is endemic worldwide; the highest rates are found in low- and middle-income countries. An estimated 823,000 cryptosporidiosis cases occur in the United States each year, of which 9.9% are thought be due to international travel.
What is the pathophysiology of cryptosporidiosis? ›Pathophysiology of Cryptosporidiosis
After Cryptosporidium oocysts are ingested, they excyst in the gastrointestinal tract and release sporozoites, which parasitize gastrointestinal epithelial cells. In these cells, the sporozoites transform into trophozoites, replicate, and produce oocysts.
Cryptosporidiosis is an illness you get from the parasite Cryptosporidium. It causes watery diarrhea that can be severe. You get cryptosporidiosis from contaminated water, like pools or lakes, or from other people.
What is the pathology of Cryptosporidium parvum? ›Cryptosporidium parvum can be regarded as a minimally invasive mucosal pathogen, since it invades surface epithelial cells that line the intestinal tract but does not invade deeper layers of the intestinal mucosa. Nonetheless, infection can be associated with diarrhea and marked mucosal inflammation.
What is the background of cryptosporidiosis? ›Human cryptosporidiosis is caused by infection with apicomplexan protozoans of the genus Cryptosporidium. Human illness was once believed to be caused by a single species, but molecular studies have demonstrated that it is caused by at least 15 different species.
What caused the Cryptosporidium outbreak? ›It is believed that the contamination was due to an ineffective filtration process. Approximately 403,000 residents were affected resulting in illness and hospitalization. Immediate repairs were made to the treatment facilities along with continued infrastructure upgrades during the 25 years since the outbreak.
What is the pathogenic stage of Cryptosporidium? ›The Cryptosporidium life cycle can be divided into six major developmental phases (33): excystation (the release of infective sporozoites), merogony (asexual multiplication within host cells), gametogony (the formation of micro- and macrogametes), fertilization (the union of micro- and macrogametes), oocyst wall ...
What is the diagnosis of cryptosporidiosis? ›When a patient has diarrhea caused by Cryptosporidium, diagnosis of cryptosporidiosis can be made by testing stool specimens. Because detection of Cryptosporidium can be difficult, patients might be asked to submit stool specimens over three days.
What kills Cryptosporidium in humans? ›Most people who have healthy immune systems will recover from cryptosporidiosis (typically diarrhea lasting days to weeks) without treatment. Nitazoxanide is a prescription medication to treat cryptosporidiosis in people with healthy immune systems and at least one year old.
What is the disease Cryptosporidium caused by? ›
Cryptosporidiosis is a disease that causes watery diarrhea. It is caused by a microscopic germ (parasite) called Cryptosporidium. This parasite can live in water, food, soil, or on surfaces that have been contaminated with infected poop.
What is the most common source of Cryptosporidium? ›Crypto may be found in soil, food, water, or surfaces that have been contaminated with the feces of infected humans or animals. Common ways Cryptosporidium is transmitted include: Swallowing contaminated water while swimming or drinking.
What is the difference between Cryptosporidium and cryptosporidiosis? ›Cryptosporidium is a parasite that causes a diarrheal illness called cryptosporidiosis (the parasite and the disease are often called “Crypto”). Crypto is a common waterborne illness and is the most common cause of recreational water illness in the United States.
Is Cryptosporidium a pathogen? ›Moreover, Cryptosporidium is one of the most important protozoan pathogen that cause waterborne outbreaks worldwide [19, 32, 38]. Cryptosporidium lives in the intestines of the infected individuals and animals in the form of oocysts, which will be released in the feces [19].
What is the life cycle of Cryptosporidium? ›Life cycle
Cryptosporidium has three developmental stages: meronts, gamonts and oocysts. They reproduce within the intestinal epithelial cells. The Cryptosporidium spore phase (oocyst) can survive for lengthy periods outside a host.
How long can an infected person infect others? Cryptosporidiosis can be very contagious. The infected person can infect others when symptoms begin and for several weeks after the symptoms disappear. Infected persons who do not have symptoms can still infect others.
How common is Cryptosporidium species in the US? ›Cryptosporidium is the leading cause of outbreaks of diarrhea linked to water and the third leading cause of diarrhea associated with animal contact in the United States. What is added by this report? During 2009–2017, 444 cryptosporidiosis outbreaks, resulting in 7,465 cases were reported by 40 states and Puerto Rico.
Where is Cryptosporidium found in the world? ›The parasite is found throughout the world. But you are more likely to get the infection if you travel to rural areas in developing countries. Or you can get it if you often eat or drink in areas where sanitation is poor.
Who is most susceptible to cryptosporidiosis? ›Children and the elderly are most commonly diagnosed with cryptosporidiosis. Patients with acquired (human immunodeficiency virus, chemotherapy, immunosuppressant medications,) or congenital (hypogammaglobulinemia; IgA deficiency) immunodeficiency are at highest risk of infection and for prolonged or severe illness.
How many people were affected by Cryptosporidium? ›For 2021, 24 European Union and European Economic Area (EU/EEA) countries reported 4 476 confirmed cryptosporidiosis cases. The notification rate was 1.8 confirmed cases per 100 000 population.